Vivere Oncotherapies Announces >$10M Funding to Develop Targeted Therapies for Solid Tumors
Funding Led by YK Bioventures With Additional Funding From Pillar, Berkeley Frontier Fund, Freeflow Ventures and The National Cancer Institute BERKELEY, Calif.–(BUSINESS WIRE)–Vivere Oncotherapies, a UC Berkeley spin-out developing cancer therapies that activate the immune…